vs

Side-by-side financial comparison of EDGEWELL PERSONAL CARE Co (EPC) and National Vision Holdings, Inc. (EYE). Click either name above to swap in a different company.

National Vision Holdings, Inc. is the larger business by last-quarter revenue ($487.3M vs $422.8M, roughly 1.2× EDGEWELL PERSONAL CARE Co). National Vision Holdings, Inc. runs the higher net margin — 0.7% vs -15.5%, a 16.2% gap on every dollar of revenue. On growth, National Vision Holdings, Inc. posted the faster year-over-year revenue change (7.9% vs -11.6%). National Vision Holdings, Inc. produced more free cash flow last quarter ($30.3M vs $-137.5M). Over the past eight quarters, National Vision Holdings, Inc.'s revenue compounded faster (7.6% CAGR vs -16.0%).

The Edgewell Personal Care Company is an American multinational consumer products company headquartered in Shelton, Connecticut. It was formed in 2015 following the corporate spin-off from Energizer Holdings, Inc..

Vision Research is an international company that manufactures high-speed digital cameras based in Wayne, New Jersey. Their cameras are marketed under the Phantom brand, and are used in a broad variety of industries including: defense, industrial product development, manufacturing, automotive, scientific research, and entertainment. Vision Research is a business unit of the Materials Analysis Division of Ametek Inc., a global manufacturer of electronic instruments and electromechanical devices.

EPC vs EYE — Head-to-Head

Bigger by revenue
EYE
EYE
1.2× larger
EYE
$487.3M
$422.8M
EPC
Growing faster (revenue YoY)
EYE
EYE
+19.6% gap
EYE
7.9%
-11.6%
EPC
Higher net margin
EYE
EYE
16.2% more per $
EYE
0.7%
-15.5%
EPC
More free cash flow
EYE
EYE
$167.8M more FCF
EYE
$30.3M
$-137.5M
EPC
Faster 2-yr revenue CAGR
EYE
EYE
Annualised
EYE
7.6%
-16.0%
EPC

Income Statement — Q1 FY2026 vs Q3 FY2025

Metric
EPC
EPC
EYE
EYE
Revenue
$422.8M
$487.3M
Net Profit
$-65.7M
$3.4M
Gross Margin
38.1%
Operating Margin
-4.5%
2.0%
Net Margin
-15.5%
0.7%
Revenue YoY
-11.6%
7.9%
Net Profit YoY
-3028.6%
139.8%
EPS (diluted)
$-1.41
$0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EPC
EPC
EYE
EYE
Q4 25
$422.8M
Q3 25
$600.5M
$487.3M
Q2 25
$627.2M
$486.4M
Q1 25
$580.7M
$510.3M
Q4 24
$415.1M
$437.3M
Q3 24
$517.6M
$451.5M
Q2 24
$647.8M
$451.7M
Q1 24
$599.4M
$482.8M
Net Profit
EPC
EPC
EYE
EYE
Q4 25
$-65.7M
Q3 25
$-30.6M
$3.4M
Q2 25
$29.1M
$8.7M
Q1 25
$29.0M
$14.2M
Q4 24
$-2.1M
$-28.6M
Q3 24
$8.8M
$-8.5M
Q2 24
$49.0M
$-3.1M
Q1 24
$36.0M
$11.7M
Gross Margin
EPC
EPC
EYE
EYE
Q4 25
38.1%
Q3 25
37.9%
Q2 25
42.8%
Q1 25
44.1%
Q4 24
41.6%
Q3 24
41.1%
Q2 24
44.3%
Q1 24
43.1%
Operating Margin
EPC
EPC
EYE
EYE
Q4 25
-4.5%
Q3 25
-4.2%
2.0%
Q2 25
8.6%
3.4%
Q1 25
10.1%
5.1%
Q4 24
2.2%
-5.8%
Q3 24
3.9%
-2.0%
Q2 24
12.8%
0.1%
Q1 24
11.7%
4.9%
Net Margin
EPC
EPC
EYE
EYE
Q4 25
-15.5%
Q3 25
-5.1%
0.7%
Q2 25
4.6%
1.8%
Q1 25
5.0%
2.8%
Q4 24
-0.5%
-6.5%
Q3 24
1.7%
-1.9%
Q2 24
7.6%
-0.7%
Q1 24
6.0%
2.4%
EPS (diluted)
EPC
EPC
EYE
EYE
Q4 25
$-1.41
Q3 25
$-0.65
$0.04
Q2 25
$0.62
$0.11
Q1 25
$0.60
$0.18
Q4 24
$-0.04
$-0.36
Q3 24
$0.18
$-0.11
Q2 24
$0.98
$-0.04
Q1 24
$0.72
$0.15

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EPC
EPC
EYE
EYE
Cash + ST InvestmentsLiquidity on hand
$56.0M
Total DebtLower is stronger
$1.5B
$236.5M
Stockholders' EquityBook value
$1.5B
$858.8M
Total Assets
$3.8B
$2.0B
Debt / EquityLower = less leverage
1.03×
0.28×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EPC
EPC
EYE
EYE
Q4 25
Q3 25
$56.0M
Q2 25
$48.5M
Q1 25
$80.0M
Q4 24
$73.9M
Q3 24
$209.1M
$81.2M
Q2 24
$179.5M
Q1 24
$150.1M
Total Debt
EPC
EPC
EYE
EYE
Q4 25
$1.5B
Q3 25
$1.4B
$236.5M
Q2 25
$1.4B
$255.6M
Q1 25
$1.4B
$244.7M
Q4 24
$1.4B
$248.6M
Q3 24
$1.3B
$252.8M
Q2 24
$1.3B
$143.9M
Q1 24
$1.4B
$448.6M
Stockholders' Equity
EPC
EPC
EYE
EYE
Q4 25
$1.5B
Q3 25
$1.6B
$858.8M
Q2 25
$1.6B
$850.6M
Q1 25
$1.5B
$836.2M
Q4 24
$1.5B
$816.3M
Q3 24
$1.6B
$840.0M
Q2 24
$1.6B
$843.4M
Q1 24
$1.6B
$841.3M
Total Assets
EPC
EPC
EYE
EYE
Q4 25
$3.8B
Q3 25
$3.8B
$2.0B
Q2 25
$3.8B
$2.0B
Q1 25
$3.8B
$2.0B
Q4 24
$3.7B
$2.0B
Q3 24
$3.7B
$2.0B
Q2 24
$3.7B
$2.1B
Q1 24
$3.8B
$2.2B
Debt / Equity
EPC
EPC
EYE
EYE
Q4 25
1.03×
Q3 25
0.89×
0.28×
Q2 25
0.88×
0.30×
Q1 25
0.95×
0.29×
Q4 24
0.97×
0.30×
Q3 24
0.81×
0.30×
Q2 24
0.82×
0.17×
Q1 24
0.88×
0.53×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EPC
EPC
EYE
EYE
Operating Cash FlowLast quarter
$-125.9M
$46.6M
Free Cash FlowOCF − Capex
$-137.5M
$30.3M
FCF MarginFCF / Revenue
-32.5%
6.2%
Capex IntensityCapex / Revenue
2.7%
3.4%
Cash ConversionOCF / Net Profit
13.83×
TTM Free Cash FlowTrailing 4 quarters
$36.3M
$83.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EPC
EPC
EYE
EYE
Q4 25
$-125.9M
Q3 25
$74.1M
$46.6M
Q2 25
$114.8M
$54.3M
Q1 25
$45.1M
$32.2M
Q4 24
$-115.6M
$30.3M
Q3 24
$-388.3M
$27.9M
Q2 24
$101.2M
$51.5M
Q1 24
$129.0M
$24.0M
Free Cash Flow
EPC
EPC
EYE
EYE
Q4 25
$-137.5M
Q3 25
$46.5M
$30.3M
Q2 25
$99.3M
$42.4M
Q1 25
$28.0M
$12.0M
Q4 24
$-132.4M
$-1.7M
Q3 24
$-414.2M
$4.1M
Q2 24
$88.6M
$31.9M
Q1 24
$117.5M
$4.0M
FCF Margin
EPC
EPC
EYE
EYE
Q4 25
-32.5%
Q3 25
7.7%
6.2%
Q2 25
15.8%
8.7%
Q1 25
4.8%
2.4%
Q4 24
-31.9%
-0.4%
Q3 24
-80.0%
0.9%
Q2 24
13.7%
7.1%
Q1 24
19.6%
0.8%
Capex Intensity
EPC
EPC
EYE
EYE
Q4 25
2.7%
Q3 25
4.6%
3.4%
Q2 25
2.5%
2.4%
Q1 25
2.9%
4.0%
Q4 24
4.0%
7.3%
Q3 24
5.0%
5.3%
Q2 24
1.9%
4.3%
Q1 24
1.9%
4.1%
Cash Conversion
EPC
EPC
EYE
EYE
Q4 25
Q3 25
13.83×
Q2 25
3.95×
6.22×
Q1 25
1.56×
2.27×
Q4 24
Q3 24
-44.13×
Q2 24
2.07×
Q1 24
3.58×
2.05×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EPC
EPC

Other$242.0M57%
Sunand Skin Care Segment$131.5M31%
Shavinggelsandcreams$32.3M8%
Wipes And Other Skin Care Products$17.0M4%

EYE
EYE

Segment breakdown not available.

Related Comparisons